GSAM fund targets “supercharged” healthcare trends

Goldman Sachs Asset Management (GSAM) has launched an equity fund based around innovation in the healthcare sector.

Four key areas of focus in the fund are genomics, precision medicine, minimally invasive procedures, and digitisation.

The Goldman Sachs Future Health Care Equity Portfolio is a sub-fud of the firm’s Luxembourg-domiciled funds Sicav, and available across Europe.

Luke Barrs, regional head of GSAM fundamental equity client portfolio management, said the pandemic has “supercharged an existing secular trend, and pushed healthcare right to the top of governments’ and societies’ priorities”.

“Specific scientific advancements – the mapping of the human genome, the application of technology to all kinds of medical procedures and increasing digitisation – is disrupting the way society has been practicing medicine for decades,” he added.

©2020 funds europe

HAVE YOU READ?

THOUGHT LEADERSHIP

The tension between urgency and inaction will continue to influence sustainability discussions in 2024, as reflected in the trends report from S&P Global.
FIND OUT MORE
This white paper outlines key challenges impeding the growth of private markets and explores how technological innovation can provide solutions to unlock access to private market funds for a growing…
DOWNLOAD NOW

CLOUD DATA PLATFORMS

Luxembourg is one of the world’s premiere centres for cross-border distribution of investment funds. Read our special regional coverage, coinciding with the annual ALFI European Asset Management Conference.
READ MORE

PRIVATE MARKETS FUND ADMIN REPORT

Private_Markets_Fund_Admin_Report

LATEST PODCAST